This site is intended for health professionals only

Wednesday 24 April 2019
LatestNews
Share |

Latest News

Blood samples to help select the right early phase clinical trials for cancer patients

Tuesday 23rd April 2019

Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines, by analysing the genetic faults in a sample of their blood, according to research published in Nature Medicine.

The researchers, funded by Cancer Research UK, The Christie Charity, AstraZeneca and the NIHR Manchester Biomedical Research Centre (BRC), demonstrated in their feasibility study that a blood test can be carried out and...

Tue, 8 Jan 2019
Mosul, Iraq’s second city, is slowly rebuilding its healthcare infrastructure after years of war and destruction. Dr Henryk Pich, a consultant anaesthetist and intensive care physician at the University of Dresden, Germany, visited the region soon after the fighting had ended, supported by the independent aid organisation CADUS
Tue, 8 Jan 2019
New plans for the NHS to tackle ‘killer conditions’ such as strokes and heart attacks could save up to half a million lives, the UK’s Government has announced.
Mon, 7 Jan 2019
NOVESA is planned to recruit 30 patients with diffuse cutaneous systemic sclerosis, an autoimmune disease involving multiorgan fibrosis, which has one of the highest mortality rates among rheumatic diseases
Mon, 7 Jan 2019
If approved, ustekinumab will be the first interleukin (IL)-12/23 inhibitor licensed for the treatment of ulcerative colitis
Fri, 21 Dec 2018
The Award encourages exceptional investigators worldwide to pursue innovative research projects that pair unconventional creativity with sound science to uncover the fundamental causes of lupus
Mon, 17 Dec 2018
Omalizumab prefilled syringe is the first and only biologic to receive European Commission approval for self-administration in severe allergic asthma and chronic spontaneous urticaria
Thu, 13 Dec 2018
There is growing evidence that the composition of the microbiome is a promising predictive tool for disease and for patient response to therapy in conditions such as IBD, cancer and liver disease